Today, the nomination committee (the “Committee”) of Episurf Medical AB (publ.) (“Episurf Medical”) is presenting its proposal for the election of two additional new board members of Episurf Medical on an extraordinary general meeting to be held on 18 August 2016. The Committee is very satisfied with the outcome of its search process. The proposed board members represent a combined 50 years of experience from the health care sector, with emphasis towards the medical technology, orthopedic and joint reconstruction sectors.
This information was published, 2016-07-26 08:35 CEST (GLOBE NEWSWIRE) —
As Episurf Medical’s technology is gaining market acceptance on a global basis, the proposed board members will add a weight of relevant experience in various capacities including sales and marketing, operations and digital health. Episurf Medical is continuing its global commercialization strategy which includes the preparation for a US market entry.
The individuals, Mr. Dennis D. Stripe and Mr. Wil Boren are both US citizens living in the United States. Mr. Stripe is proposed as Chairman of the Board of Directors of Episurf Medical.
Commenting on the nominations, Ashkan Pouya, Chairman of the Committee, said “Dennis and Wil will add significant and relevant expertise to Episurf Medical, earned from decades in the global orthopedic industry and tailored orthopedic solutions in particular. The nomination is a continuation of the development of the Board of Directors which has been ongoing during the year. Lastly, we are very happy to get these individuals onboard as there are few individuals out there with such a deep and specific knowledge about highly relevant disciplines for Episurf.”
“The technology that Episurf Medical brings to the medical world is exciting as it combines the latest in design and manufacturing for implant customization. Episurf Medical is an example of surgeons and industry working together to address a younger patient, with a goal of regaining a mobile lifestyle using minimally invasive surgical techniques. It will be a pleasure to work with Rosemary and the talented employees of Episurf Medical”, says Mr. Dennis Stripe, proposed new Chairman.
Mr. Wil Boren stated, “I am excited for the opportunity to serve on the Board of Directors for Episurf Medical. The evolution of personalized minimally invasive orthopedic solutions will truly shape the future of patient care. Episurf Medical has the strategic pathway and pipeline to significantly redefine the future of our industry.”
Summaries of professional background
DENNIS D. STRIPE
Mr. Dennis Stripe has almost 40 years of experience from various positions in management, sales and marketing on a global basis. When joining Kendall Healthcare Products in 1983, Mr. Stripe started a career within the healthcare industry lasting 33 years. In 1991, Mr. Stripe joined Smith & Nephew as a Senior Product Manager. During his time at Smith & Nephew, Mr. Stripe held various senior positions with Marketing, ending as a Group Marketing Director within the Orthopedic Division. Following a successful career at Smith & Nephew, Mr. Stripe joined the Spine Division of Stryker Corporation in 1996 and remained there until 2008. At Stryker Corporation, Mr. Stripe held several senior management roles on a global basis, including the Vice President of Global Marketing. In 2008, Mr. Stripe joined OrthoHelix Surgical Designs, a medical technology company focusing on implants and instruments for reconstruction surgery. Mr Stripe remained at OrthoHelix Surgical Designs until 2013 and served as Chief Executive Officer and as member of the Board of Directors for five years. OrthoHelix Surgical Designs was ultimately sold to Nasdaq listed company Tornier N.V., a transaction led by Mr. Stripe.
Mr. Stripe is currently a key executive of California based Compliant Innovations, a company focusing on software solutions for the healthcare industry, as well as a member of the Board of Directors of Central-Insurance Companies and Medshape.
Mr. Stripe is married with three children and lives in Mahwah, New Jersey, United States. Mr. Stripe earned his BA in Marketing from Ohio Northern University in 1979. In addition, Mr. Stripe has engaged in executive education at Harvard University and Wharton School of Business.
Mr. Wil Boren has 17 years of experience in orthopedics. Mr. Boren joined the Sports Medicine Division of Biomet Orthopedics in 1999. During the following eight years, Mr. Boren held several senior positions in sales and marketing, both on division level as well as on corporate level. In 2007, Mr. Boren assumed the position as President of Biomet’s International Division. In this role, Mr. Boren was responsible for Asia Pacific, Latin America and Canada. In 2013, Mr. Boren assumed the position as President for the Sports Medicine, Extremities and Trauma Division of Biomet.
In 2015, following the acquisition of Biomet by Zimmer, Mr. Boren led companywide strategic initiatives as General Manager for Connected Health, Global Branding and Medical Education. Mr. Boren left Zimmer|Biomet during the summer of 2016.
Mr. Boren is married with four children and lives in Warsaw, Indiana, United States. Mr. Boren earned his Bachelor of Science from Indiana University in 1996 and is a Wharton Business School Fellow.
The Committee’s complete proposal is available at Episurf medical’s website, Episurf.com.
For more information, please contact:
Ashkan Pouya, Chairman of the Committee
Tel: +46 (0) 707 983 244
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.
This information is information that Episurf Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.35 CET on 26 July 2016.